Funambol raises $12.5 million, scores deal with AOL

Funambol raises $12.5 million, scores deal with AOL

Funambol has raised $12.5 million in venture funding to fuel its open-source mobile messaging software business. On top of that, the company is announcing today that it’s landed AOL as a customer for its mobile synchronization software.

Funambol raised its second round from Nexit Ventures (which… Continue Reading

Life sciences briefing: Friday, Feb. 15, 2008

Life sciences briefing: Friday, Feb. 15, 2008

TODAY’S HEADLINES:

Q Thera takes in $15M for neural stem-cell treatments (release)
Stroke clotbuster Concentric Medical withdraws IPO (IPOhome)
Avera recaps with $9M to relaunch human tests of GI drug (VentureWire)
Tissue repairer Nerites raises $5.7M (release)
Semafore Pharma aims for $7.5M to launch new cancer-drug trials (VentureWire)
Triage Wireless gets… Continue Reading

Suniva, a solar photovoltaic maker, readies for production with $50M

Suniva, a solar photovoltaic maker, readies for production with $50M

A stealthy Georgia-based startup with plans to manufacture silicon-based solar cells unveiled itself this morning, announcing a hefty $50 million financing that will help it start production.

The company, called Suniva, says its cells operate at about 18 percent efficiency, near 50 percent better than the… Continue Reading

Alder Bio and its yeast-produced antibodies take in $40M

Alder Bio and its yeast-produced antibodies take in $40M

Alder Biopharmaceuticals, a Bothell, Wash., developer of antibody drugs, raised $40 million in a third funding round. Investors included Delphi Ventures, TPG Biotech, Sevin Rosen Funds, Ventures West, H.I.G. Ventures, and WRF Capital.

Alder develops antibody-based drugs for inflammation and autoimmune disease. The company’s lead candidate,… Continue Reading

REVShare, raises $20M for cost-per-action TV ad network

REVShare, a Temecula, Calif.’ company that lets advertisers to bid for television time on a cost-per-action basis, has raised $20 million in a first round of funding.
The private equity firm Carlyle Group and H.I.G. Ventures co-led the round.

The auction/exchange model contrasts with the traditional method… Continue Reading

Inovys, structural testing for semiconductors, acquired by Verigy

Inovys, a Pleasanton, Calif. company that makes software and hardware for structural testing of semiconductors, was founded in 1999.

The company picked up nearly $40 million in funding over the years, from venture investors including Storm Ventures, CMEA Ventures, Palomar Ventures, Techfarm, HIG Ventures and Hotung… Continue Reading

NorthStar Systems takes a further $18M for wealth management

NorthStar Systems International is a San Francisco, Calif. company that makes wealth management software for the financial services industry.

The $18 million financing wasn’t broken down by investor, but members of three firms did join the company’s board: Ropart Asset Management, TL Ventures and Trinad Capital.

The… Continue Reading

Life sciences briefing: Thursday, Nov. 1, 2007

Life sciences briefing: Thursday, Nov. 1, 2007

Featured companies: Asteres, HemaQuest Pharmaceuticals, Nanosphere, Novalar Pharmaceuticals, Tranzyme Pharma

(UPDATED: Expanded items for Nanosphere, HemaQuest and Transzyme. Moved Novalar to a separate item here.)

Diagnostic maker Nanosphere prices IPO at low end of range, raises up to $113M — Nanosphere, a Northbrook, Ill., biotech focused on nanotech-derived diagnostics,… Continue Reading

Life sciences briefing: Tuesday, Oct. 9, 2007

Life sciences briefing: Tuesday, Oct. 9, 2007

Featured companies: AngioScore, Forsight Labs, Genoptix, Metastatix, Optherion, QLT

UPDATED: See below.

Artery opener AngioScore pulls in $30M — AngioScore, a Fremont, Calif., maker of balloon catheters used to open up clogged arteries, raised $30 million in a fifth funding round. Investors included Telegraph Hill Partners, Psilos Group Management,… Continue Reading

Life sciences briefing: Monday, Oct. 8, 2007

Life sciences briefing: Monday, Oct. 8, 2007

Featured companies: AirInSpace, Anacor Pharmaceuticals, Apollo Endosurgery, Ascension Health Partners, BG Medicine, CeraPedics, GlaxoSmithKline, Simplex Diabetic Supply, Zars Pharma

UPDATED: Last entry added at 2am PT on 10/8/07.

Anacor Pharma pulls in $22M from Glaxo, with hundreds of millions more on the line –Palo Alto, Calif.-based Anacor Pharmaceuticals, a… Continue Reading

Life sciences briefing: Monday, Aug. 20, 2007

Life sciences briefing: Monday, Aug. 20, 2007

(UPDATED at 7:10pm PT: See below.)

Featured companies: NeurAxon, VytronUS, Avila Therapeutics, CardioNet, Ventana Medical Systems, CytoLogix, PlaCor

NeurAxon raises $32M for pain drugs — You have to hand it to Waltham, Mass.-based NeurAxon — the company certainly knows how to keep itself in the news. Today, it announced… Continue Reading

Open-source mobile app server co., Funambol, raises $5.35M

Funambol, a Redwood City, Calif. developer of open-source mobile application servers, has secured $5.35 million of a $10 million Series B round, according to a regulatory filing cited by PE Week. Return backers include HIG Ventures and Walden Ventures.

(First posted 1/18)